Javascript must be enabled to continue!
A Retrospective Analysis for Risk Factors and Early Prognosis of Delayed Withdrawal Extracorporeal Membrane Oxygenation After Lung Transplantation
View through CrossRef
Background.
Extracorporeal membrane oxygenation (ECMO) is widely used for cardiopulmonary assistance during lung transplantation (LTx). However, the optimal timing for ECMO removal remains controversial. This study aimed to evaluate the risk factors and early prognosis of delayed withdrawal ECMO after LTx.
Methods.
Two hundred sixty-seven patients who underwent LTx supported by ECMO were included in this study. Based on whether or not ECMO was completely stopped in the operating room, patients were divided into early ECMO withdrawal group (group E, 107 cases) and delayed withdrawal group (group D, 160 cases). Perioperative data of the donors and recipients, including the suspected risk factors for delayed removal of ECMO, postoperative complications, and hospital survival rate, were retrospectively analyzed.
Results.
Preoperative New York Heart Association cardiac function for recipients and mechanical ventilation time for donors were independent risk factors for delayed weaning of ECMO in veno-arterial ECMO patients. Compared with group E, the odds of postoperative pulmonary infection, primary graft dysfunction, renal dysfunction, blood transfusion volume, and mechanical ventilation time were significantly higher in group D (all P < 0.05). Delayed withdrawal ECMO was decisive factor for early postoperative death, as the risk of early postoperative death in group D was 1.99 (95% confidence interval, 1.13-3.54) times as that in the group E.
Conclusions.
During the period of LTx, New York Heart Association grade III/IV for recipients and mechanical ventilation time ≥5 days for donors are suggestive of delayed veno-arterial ECMO removal, and clinicians should minimize the postoperative bypass time of ECMO when conditions permit.
Ovid Technologies (Wolters Kluwer Health)
Title: A Retrospective Analysis for Risk Factors and Early Prognosis of Delayed Withdrawal Extracorporeal Membrane Oxygenation After Lung Transplantation
Description:
Background.
Extracorporeal membrane oxygenation (ECMO) is widely used for cardiopulmonary assistance during lung transplantation (LTx).
However, the optimal timing for ECMO removal remains controversial.
This study aimed to evaluate the risk factors and early prognosis of delayed withdrawal ECMO after LTx.
Methods.
Two hundred sixty-seven patients who underwent LTx supported by ECMO were included in this study.
Based on whether or not ECMO was completely stopped in the operating room, patients were divided into early ECMO withdrawal group (group E, 107 cases) and delayed withdrawal group (group D, 160 cases).
Perioperative data of the donors and recipients, including the suspected risk factors for delayed removal of ECMO, postoperative complications, and hospital survival rate, were retrospectively analyzed.
Results.
Preoperative New York Heart Association cardiac function for recipients and mechanical ventilation time for donors were independent risk factors for delayed weaning of ECMO in veno-arterial ECMO patients.
Compared with group E, the odds of postoperative pulmonary infection, primary graft dysfunction, renal dysfunction, blood transfusion volume, and mechanical ventilation time were significantly higher in group D (all P < 0.
05).
Delayed withdrawal ECMO was decisive factor for early postoperative death, as the risk of early postoperative death in group D was 1.
99 (95% confidence interval, 1.
13-3.
54) times as that in the group E.
Conclusions.
During the period of LTx, New York Heart Association grade III/IV for recipients and mechanical ventilation time ≥5 days for donors are suggestive of delayed veno-arterial ECMO removal, and clinicians should minimize the postoperative bypass time of ECMO when conditions permit.
Related Results
Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality
Venoarterial extracorporeal membrane oxygenation in adult patients: predictors of mortality
Background: Extracorporeal membrane oxygenation is a cardiopulmonary supportive therapy. In this study, we reviewed our experience with extracorporeal membrane oxygenation support ...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Impact of Cannulation Strategy and Extracorporeal Blood Flow on Recirculation During Veno‐Venous Extracorporeal Membrane Oxygenation
Impact of Cannulation Strategy and Extracorporeal Blood Flow on Recirculation During Veno‐Venous Extracorporeal Membrane Oxygenation
ABSTRACTIntroductionVeno‐venous extracorporeal membrane oxygenation (V‐V ECMO) is increasingly used in the treatment of severe respiratory failure. Despite a significant increase i...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Unanticipated Benzodiazepine Withdrawal in the Context of an Adulterated Unregulated Opioid Supply in Vancouver, BC: A Case Series
Unanticipated Benzodiazepine Withdrawal in the Context of an Adulterated Unregulated Opioid Supply in Vancouver, BC: A Case Series
ABSTRACT
Background:
Novel psychoactive substance (NPS) benzodiazepines have emerged as frequent adulterants of the unregulated opioid supply in ...
Risk factors for early mortality (within 90 days) in pediatric liver transplant recipients
Risk factors for early mortality (within 90 days) in pediatric liver transplant recipients
Liver transplantation (LT) is a potential treatment for acute or chronic conditions of the liver that cause the body to function irreversibly and severely. Studies have been conduc...

